AbbVie Other Long-Term Assets 2010-2025 | ABBV

AbbVie other long-term assets for the quarter ending March 31, 2025 were $9.192B, a 1.38% increase year-over-year.

  • AbbVie other long-term assets for 2024 were $9.142B, a 7.39% increase from 2023.
  • AbbVie other long-term assets for 2023 were $8.513B, a 52.81% increase from 2022.
  • AbbVie other long-term assets for 2022 were $5.571B, a 14.07% increase from 2021.

AbbVie Other Long-Term Assets 2010-2025 | ABBV

  • AbbVie other long-term assets for 2024 were $9.142B, a 7.39% increase from 2023.
  • AbbVie other long-term assets for 2023 were $8.513B, a 52.81% increase from 2022.
  • AbbVie other long-term assets for 2022 were $5.571B, a 14.07% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$765.9B
Johnson & Johnson (JNJ)$400.3B
Novo Nordisk (NVO)$308.1B
Roche Holding AG (RHHBY)$258.9B
Novartis AG (NVS)$245.4B
Merck (MRK)$211.1B
Pfizer (PFE)$138.2B
Sanofi (SNY)$121.3B
Bayer (BAYRY)$32.8B
Innoviva (INVA)$1.2B